Appetite Suppressant Phentermine and TopiramateAuthor: Oksana Aron, MD Source: Weight Loss NYC Jul 22, 2010
Combination of appetite suppressant phentermine and topiramate was disapproved.
A panel of experts advising the US Food and Drug Administration voted against approving for sale a new obesity treatment called Qnexa, citing safety risks. Qnexa combines two existing drugs, the appetite suppressant phentermine and topiramate.
— Oksana Aron, MD, July 16 2010
Labels: appetite, fda, health, medication, prescription, weight loss pills